G-Proteins Agonists and NO/cGMP Blockers: Unexplored Frontiers in the Pharmaceutical Industry

Evora, Paulo Roberto B

G-Proteins Agonists and NO/cGMP Blockers: Unexplored Frontiers in the Pharmaceutical Industry / Agonistas de Proteínas G e Bloqueadores da via NO/cGMP: Duas Fronteiras não Exploradas pelas Indústrias Farmacêuticas

Evora, Paulo Roberto B.

Evora, Paulo Roberto B; Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Departamento de Cirurgia e Anatomia. São Paulo. BR

Arq. bras. cardiol ; 109(4): 275-276, Oct. 2017. graf

Article in English | LILACS | ID: biblio-887943

Subject(s)

Humans; Drug Design; Cyclic GMP/antagonists & inhibitors; GTP-Binding Proteins/agonists; Drug Industry; Vasoplegia/drug therapy; Nitric Oxide/antagonists & inhibitors; Vasoplegia/metabolism

Celulas Endoteliais; Endothelial Cells; GTP-Binding Proteins; Medicamentos de Referência; Nitric Oxide; Proteinas de Ligação ao GTP; Reference Drugs; Technology Pharmaceutical; Tecnologia Farmacêutica

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Drug Design / Cyclic GMP / GTP-Binding Proteins / Drug Industry / Vasoplegia / Nitric Oxide Limits: Humans Language: English Journal: Arq. bras. cardiol Journal subject: Cardiology Year: 2017 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade de São Paulo/BR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google